Product Images Wixela Inhub
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 35 images provide visual information about the product associated with Wixela Inhub NDC 0378-9320 by Mylan Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a table of data related to the use of Fluicasone propionate and Salmeterol as a treatment for some medical condition. There are some numerical values mentioned such as the quantity of Fluicasone propionate and Salmeterol to be taken twice daily. The table also seems to indicate the progress of the treatment over several weeks. However, without additional context or better results, it is difficult to provide further details.*
The text describes a table or graph showing the percentage change in FEV on the first treatment day of four different medications, including Fluticasone propionate and Salmeterol. The number of participants for each medication is also mentioned. A baseline measurement is also shown.*
This is a description of a study that evaluates the efficacy of Fluticasone propionate and Salmeterol inhalation powder in patients with a baseline forced expiratory volume (FEV) of 1207 mL. The patients were divided into two groups, one group received 250mog/50mog of Fluticasone propionate and Salmeterol twice daily, and the other group received a placebo. The study reports the percentage change in FEV at various endpoints.*
This appears to be a medical study's results regarding the impact of using Fluticasone propionate and Salmeterol inhalation to improve FEV (forced expiratory volume) in individuals. The study involved using different doses of Fluticasone propionate and a placebo. The results show the changes in FEV after different treatments.*
Wixela is a medication used for oral inhalation only. It contains fluticasone propionate and salmeterol inhalation powder. The dosage should be taken as directed by your doctor. The medication comes in a powder form, which needs to be inhaled. The inhaler needs to be stored at a controlled temperature between 20°C and 25°C. The inhaler needs to be discarded after use. After inhalation, you should rinse your mouth with water. If you face any issues or have any doubts, consult your doctor.*
Wixela is a prescribed inhalation powder, for oral use only. It contains fluticasone propionate and salmeterol, which are bronchodilators that help to make breathing easier by relaxing muscles in the airways. Each container holds 60 doses of inhalation powder. Before using it, read the enclosed patient information. The inhaler is easy to use, and each dose contains 500 mcg of fluticasone proponats and 72.5 g of salmeterol base. After use, rinse your mouth with water. Store the product in a cool, dry place, between 68-77 degrees Fahrenheit.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.